The Eshmuno® A resin contains a Merck Millipore proprietary ligand. This ligand is recombinantely expressed in E. coli. No animal derived products are used during production. The Eshmuno® A resin is synthesized via immobilization of the ligand on to the Eshmuno® base matrix, which is a rigid and hydrophilic polymer based on polyvinylether.
Eshmuno® A resin earns an "AAA rating" for its –
Eshmuno® A resin further exhibits excellent –
High Binding Capacity
Optimizing the particle and pore size of the Eshmuno® base matrix along with the immobilization of the Merck Millipore proprietary ligand enables a significant increase in dynamic binding capacity. Eshmuno® A resin shows higher dynamic binding capacity than other commercially available media. The sharp breakthrough curve allows for higher loading of Fc-containing protein to be purified, thereby maximizing column throughput.
The combination of optimized particle size and high dynamic binding capacity at high flow rate translates into high productivity of Eshmuno® A media.